What cannabis investors should watch for in 2026 after marijuana rescheduling
Cannabis investors need to know marijuana rescheduling by itself won't create conditions for a 2026 moonshot.
News December 26Cannabis investors need to know marijuana rescheduling by itself won't create conditions for a 2026 moonshot.
News December 26With President Donald Trump’s executive order to reschedule marijuana, operators in the $32 billion cannabis industry are anticipating…
News December 23The Cannabist Co. will sell its Virginia medical marijuana permit for $130 million plus a $30 million lease…
News December 22Marijuana rescheduling is an enormous win and a transformative shift, but it won't make business easier overnight, our…
News December 19President Donald Trump moved federal marijuana reform forward with an executive order rescheduling cannabis as a less dangerous…
News December 18Cannabis MSO PharmaCann is selling some of its Colorado retail assets to Vireo Growth Inc. for $49 million…
News December 17Prominent right-wing media figures and lawmakers alike sounded the alarm over President Donald Trump's consideration of marijuana rescheduling.
News December 17President Donald Trump is expected to issue an executive order reclassifying cannabis under federal law, the Washington Post…
News December 11Sales tumbled after lawmakers hiked California cannabis taxes, recent data shows.
News December 8In a deal that reflects cannabis industry excitement over Virginia, Curaleaf announced plans to enter the market with…
News December 3